Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-07-26

FDA Approved: IXEMPRA — Supplemental Application (R-Pharm US Operating, LLC)

View source ↗

Summary

FDA approved a supplemental application for IXEMPRA (ixabepilone) from R-Pharm US Operating, LLC, resulting in updated labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ixempra (ixabepilone)

Snippet

SUPPL AP for IXEMPRA (IXABEPILONE)